Cargando…

Survival after recurrence in patients with gastric cancer who receive S-1 adjuvant chemotherapy: exploratory analysis of the ACTS-GC trial

BACKGROUND: Some patients develop recurrence after curative resection and adjuvant chemotherapy. S-1, an oral fluoropyrimidine, is one of the standard regimens in adjuvant chemotherapy, and is also used in first-line treatment for advanced/metastatic gastric cancer. It is controversial as to whether...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ito, Seiji, Ohashi, Yasuo, Sasako, Mitsuru
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5910584/ https://www.ncbi.nlm.nih.gov/pubmed/29678146 http://dx.doi.org/10.1186/s12885-018-4341-6

Ejemplares similares

Cost-effectiveness of adjuvant chemotherapy for curatively resected gastric cancer with S-1
por: Hisashige, Akinori, et al.
Publicado: (2013)

TOP2A, GGH, and PECAM1 are associated with hematogenous, lymph node, and peritoneal recurrence in stage II/III gastric cancer patients enrolled in the ACTS-GC study
por: Terashima, Masanori, et al.
Publicado: (2017)

Intraperitoneal Chemotherapy as Adjuvant or Perioperative Chemotherapy for Patients with Type 4 Scirrhous Gastric Cancer: PHOENIX-GC2 Trial
por: Ishigami, Hironori, et al.
Publicado: (2021)

Impact of insulin-like growth factor-1 receptor and amphiregulin expression on survival in patients with stage II/III gastric cancer enrolled in the Adjuvant Chemotherapy Trial of S-1 for Gastric Cancer
por: Ichikawa, Wataru, et al.
Publicado: (2016)

A prospective study of surgery and adjuvant chemotherapy for primary gastric lymphoma stage II.
por: Takenaka, T., et al.
Publicado: (1997)

Nomogram for predicting the survival of gastric adenocarcinoma patients who receive surgery and chemotherapy
por: Wang, Chao-Yang, et al.
Publicado: (2020)

Implication of KDR Polymorphism rs2071559 on Therapeutic Outcomes and Safety of Postoperative Patients with Gastric Cancer Who Received S-1-Based Adjuvant Chemotherapy: A Real-World Exploratory Study
por: Meng, Lei, et al.
Publicado: (2023)

Progress in the treatment of gastric cancer in Japan over the last 50 years
por: Sasako, Mitsuru
Publicado: (2020)

Adjuvant capecitabine plus oxaliplatin after D2 gastrectomy in Japanese patients with gastric cancer: a phase II study
por: Fuse, Nozomu, et al.
Publicado: (2016)

Adjuvant chemotherapy after radical cystectomy: Do all patients who need chemotherapy after surgery actually receive it?
por: Croock, Roy, et al.
Publicado: (2023)

Protein-bound polysaccharide K prolonged overall survival in gastric cancer patients from a non-Japanese Asian country who received gastrectomy and adjuvant chemotherapy
por: Wang, Ting-Yao, et al.
Publicado: (2022)

A Prognostic Model in Metastatic or Recurrent Gastric Cancer Patients with Good Performance Status Who Received First-Line Chemotherapy()
por: Wang, Jin, et al.
Publicado: (2016)

BRCA1 and STMN1 as prognostic markers in NSCLCs who received cisplatin-based adjuvant chemotherapy
por: Wang, Mingxing, et al.
Publicado: (2017)

Prognosis of selected triple negative apocrine breast cancer patients who did not receive adjuvant chemotherapy
por: Montagna, Emilia, et al.
Publicado: (2020)

MAP3K1 rs889312 genotypes influence survival outcomes of Chinese gastric cancer patients who received adjuvant chemotherapy based on platinum and fluorouracil regimes
por: Yang, Jian, et al.
Publicado: (2019)

Clinical benefit and tolerability of adjuvant intraperitoneal chemotherapy in patients who have or have not received neoadjuvant chemotherapy for advanced ovarian cancer
por: Meghal, Trishala, et al.
Publicado: (2019)

The effect of smoking, obesity and diabetes on recurrence‐free and overall survival in patients with stage III colon cancer receiving adjuvant chemotherapy
por: Croese, Alex, et al.
Publicado: (2021)

Updated Adjuvant Chemotherapy for Gastric Cancer
por: Takayama, Toshizo, et al.
Publicado: (2023)

Metabolic tumor burden predicts prognosis of ovarian cancer patients who receive platinum‐based adjuvant chemotherapy
por: Yamamoto, Makoto, et al.
Publicado: (2016)

Predictive value of chemotherapy-related high-density lipoprotein cholesterol (HDL) elevation in patients with colorectal cancer receiving adjuvant chemotherapy: an exploratory analysis of 851 cases
por: Wang, Yun, et al.
Publicado: (2016)

Survival impact of microsatellite instability in stage II gastric cancer patients who received S-1 adjuvant monotherapy after curative resection
por: Sato, Chihiro, et al.
Publicado: (2023)

Multimodal Prediction of Five-Year Breast Cancer Recurrence in Women Who Receive Neoadjuvant Chemotherapy
por: Rabinovici-Cohen, Simona, et al.
Publicado: (2022)

Preoperative Nutritional Status Contributes to the Development of Neutropenia Event in Patients With Gastric Cancer Receiving CAPEOX Adjuvant Chemotherapy
por: Xiao, Ai Tang, et al.
Publicado: (2020)

Prediction of chemotherapy benefit by EndoPredict in patients with breast cancer who received adjuvant endocrine therapy plus chemotherapy or endocrine therapy alone
por: Sestak, Ivana, et al.
Publicado: (2019)

Prognostic and Predictive Model for Stage II Colon Cancer Patients With Nonemergent Surgery: Who Should Receive Adjuvant Chemotherapy?
por: Zhang, Chun-Dong, et al.
Publicado: (2016)

Retrospective analysis of the efficacy of adjuvant CIK cell therapy in epithelial ovarian cancer patients who received postoperative chemotherapy
por: Zhou, Yun, et al.
Publicado: (2018)

Risk Profiling of Cancer Treatment-Related Cardiovascular Disorders in Breast Cancer Patients Who Received Adjuvant Chemotherapy With Trastuzumab
por: Shinano, Hiromi, et al.
Publicado: (2020)

Rs11479 in Thymidine Phosphorylase Associated with Prognosis of Patients with Colorectal Cancer Who Received Capecitabine-Based Adjuvant Chemotherapy
por: Jia, Xiongjie, et al.
Publicado: (2023)

Update of Adjuvant Chemotherapy for Resected Gastric Cancer
por: Oh, Sang Cheul
Publicado: (2012)

Actual compliance to adjuvant chemotherapy in gastric cancer
por: Kim, Dong-Wook, et al.
Publicado: (2019)

Current status of adjuvant chemotherapy for gastric cancer
por: Kim, In-Hwan
Publicado: (2019)

Is adjuvant chemotherapy necessary for early gastric cancer?
por: Mei, Yu, et al.
Publicado: (2022)

Optimizing the Choice for Adjuvant Chemotherapy in Gastric Cancer
por: Grassadonia, Antonino, et al.
Publicado: (2022)

Exploratory analysis of immune checkpoint receptor expression by circulating T cells and tumor specimens in patients receiving neo-adjuvant chemotherapy for operable breast cancer
por: Wesolowski, Robert, et al.
Publicado: (2020)

Adjuvant radiotherapy and chemotherapy improve survival in patients with pancreatic adenocarcinoma receiving surgery: adjuvant chemotherapy alone is insufficient in the era of intensity modulation radiation therapy
por: Hsieh, Mao‐Chih, et al.
Publicado: (2018)

Incorporation of liver chemistry score in predicting survival of liver‐involved advanced gastric cancer patients who received palliative chemotherapy
por: Feng, Ying, et al.
Publicado: (2022)

Evaluations of primary lesions by endoscopy clearly distinguishes prognosis in patients with gastric cancer who receive chemotherapy
por: Tahara, Tomomitsu, et al.
Publicado: (2017)

The Clinical Implication of Conversion Surgery in Patients with Stage IV Gastric Cancer Who Received Systemic Chemotherapy
por: Shin, Min-Kyue, et al.
Publicado: (2023)

Non-Randomized Confirmatory Trial of Laparoscopy-Assisted Total Gastrectomy and Proximal Gastrectomy with Nodal Dissection for Clinical Stage I Gastric Cancer: Japan Clinical Oncology Group Study JCOG1401
por: Kataoka, Kozo, et al.
Publicado: (2016)

Role of adjuvant chemotherapy on recurrence and survival in patients with resected ampulla of Vater carcinoma
por: Park, Se Jun, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_sc7lq2rk72angahvoe544indc7